ReviewMetabolites2020

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.

Alessandro Mantovani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.